TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro

Anticancer Research

Volumn 20, Issue 1 C, 2000, Pages 601-604

  Emoto, Makoto ^a,b   Ishiguro, Masako ^a   Iwasaki, Hiroshi ^a   Kikuchi, Masahiro ^a   Kawarabayashi, Tatsuhiko ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Carcinosarcoma; MTT assay; TNP 470; Uterus; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE; VASCULOTROPIN;

CANCER INHIBITION; CARCINOSARCOMA; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA CELL; UTERUS SARCOMA;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOSARCOMA; CELL DIVISION; CULTURE MEDIA; CYCLOHEXANES; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; SESQUITERPENES; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034108911     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? Natl Cancer Inst 82: 4-6, 1990.
2. Fidler IJ and Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994.
3. Leek RD, Harris AL and Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukocyte Biol 56: 423-435, 1994.
4. Kusaka M, Sudo K, Matsutani E, et al: Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer 69: 212-216, 1994.
5. Yanase T, Tamura M, Fujita K, et al: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 53: 2566-2570, 1993.
6. Yamaoka M, Yamamoto T, Masaki T, et al: Inhibition of tumor growth and metastasis of rodent tumor by the angiogenesis inhibitor O-(chloroacethycarbamoyl) fumagillol (TNP-470, AGM-1470). Cancer Res 53: 4262-4267, 1993.
7. Yamaoka M, Yamamoto T, Ikeyama S, et al: Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 53: 5233-5236, 1993.
8. Tanaka T, Konno H, Matsuda I, et al: Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res 55: 836-839, 1995.
9. Shishido T, Yasoshima T, Denno R, et al: Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470. Jpn J Cancer Res 87: 958-962, 1996.
10. Miki T, Nonomura N, Nozawa M, et al: Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of hormone-independent rat prostatic carcinoma cell line. J Urology 160: 210-213, 1998.
11. Gleich LL, Zimmerman N, Wang YO, Gluckman JL: Angiogenic inhibition for the treatment of head and neck cancer. Anticancer Res 18(4A): 2607-2609, 1998.
12. Salazar OM, Bonfiglio TA, Patten SF, et al: Uterine sarcomas: Natural history, treatment and prognosis. Cancer 42(3): 1152-1160, 1978.
13. Spanos WJ, Wharton JT, Gomez L, et al: Malignant mixed mullerian tumors of the uterus. Cancer 53: 311-316, 1984.
14. Nielsen SN, Podratz KC, Scheithauer BW, et al: Clinicopathologic analysis of uterine malignant mixed mullerian tumors. Gynecol Oncol 34: 372-378, 1989.
15. Emoto M, Iwasaki H, Kikuchi M et al: Two cell lines established from mixed mullerian tumors of the uterus: Morphological immunocytochemical, and cytogenetic analyses. Cancer 69: 1759-1768, 1992.
16. Silverberg SG, Major FJ, Blessing JA et al: Carcinosarcoma (malignant mixed mesodermal tumors of the uterus: A gynecologic oncology group pathologic study of 203 cases. Int J Gynecol Pathol 9: 1-19, 1990.
17. Bitterman P, Chun BK, Kurman RJ: The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. Am J Surg Pathol 14(4): 317-328, 1990.
18. Sreenan JJ, Hart WR: Carcinosarcomas of the female genital tract: A pathologic study of 29 metastatic tumors: Further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 19: 666-674, 1995.
19. Emoto M, Udo T, Kubota M, et al: Neovasculavization of Uterine Carcinosarcoma. J Ultrasound Medicine 18: 315-319, 1999.
20. Ferrara N: Vascular endothelial growth factor. Europ J Cancer 32A: 2413-2422, 1996.
21. Hanahan D, and FoLkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
22. Leung DW, Cachianes G, Kuang W-J. et al: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1312, 1989.
23. Plate KH, Breier G, Weich HA, et al: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.) 359: 845-848, 1992.